Thrombin cleavable linker with XTEN and its uses thereof

AU2026205478A1Pending Publication Date: 2026-07-30BIOVERATIV THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
BIOVERATIV THERAPEUTICS INC
Filing Date
2026-07-09
Publication Date
2026-07-30

Smart Images

  • Figure 00000140_0000
    Figure 00000140_0000
  • Figure 00000140_0001
    Figure 00000140_0001
  • Figure 00000142_0000
    Figure 00000142_0000
Patent Text Reader

Abstract

The present invention provides a chimeric molecule comprising a VWF protein fused to a heterologous moiety via a VWF linker. The invention provides an efficient VWF linker that can be cleaved in the presence of thrombin. The chimeric molecule can further comprise a polypeptide chain comprising a FVIII protein and a second heterologous moiety, wherein the chain comprising the VWF protein and the chain comprising the FVIII protein are associated with each other. The invention also includes nucleotides, vectors, host cells, methods of using the chimeric proteins. 20 26 20 54 78 09 J ul 2 02 6 2 0 2 6 2 0 5 4 7 8 0 9 J u l 2 0 2 6
Need to check novelty before this filing date? Find Prior Art